Your Location:
Home >
Browse articles >
Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
- Military Medical Research Vol. 3, Issue 2, Pages: 73-79(2016)
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 4 )
References
Publication Info
Metrics
12
Views
14
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Chinese expert consensus on prevention, diagnosis, and management of venous thromboembolism in adult burn patients (2024)
Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus
Physician-level variation in the diagnosis of myocardial infarction and the use of angiography among veterans with elevated troponin
Role of thrombus precursor protein in assessment of anticoagulation in patients with atrial fibrillation after mechanical heart valve replacement
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
Related Author
Xiao-Bing Fu
Feng Zhu
Xiao-Bin Liu
Wei Zhou
Tuo Shen
Qi-Min Ma
Yu-Song Wang
Wen-Bin Tang
Related Institution
Key Laboratory of Wound Repair and Regeneration of PLA, the Fourth Medical Center of PLA General Hospital
Department of Wound Repair, Institute of Wound Repair and Regeneration Medicine, Southern University of Science and Technology Hospital, Southern University of Science and Technology School of Medicine
Department of Burns and Plastic Surgery, Shanghai Children’s Medical Center, Shanghai Jiaotong University
Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital of Nanchang University
Department of Burns, Zhangjiagang First People’s Hospital

